CA Stock MarketDetailed Quotes

Antibe Therapeutics Inc (ATE)

Watchlist
  • 0.295
  • 0.0000.00%
15min DelayMarket Closed Apr 12 09:30 ET
15.64MMarket Cap-0.84P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Antibe Therapeutics Inc (ATE) Revenue Breakdown Overview

By Business/Source

Currency:CAD
2020/FY
Stock NameRevenueRatio
Citagenix9.67M100.00%

By Product

No Data

By Industry

No Data

By Country/Region

Currency:CAD
2018/FY
Stock NameRevenueRatio
Canada, United States and Germany8.51M100.00%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +5.26%
Sample Name
Sample Code
 -2.00%
Sample Name
Sample Code
 -4.69%
4
SINOPEC CORP
00386
-8.50%
5
KUNLUN ENERGY
00135
-10.30%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.11%
Sample Name
Sample Code
 +15.55%
Sample Name
Sample Code
 +8.32%
4
Rockchip Electronics
603893
+0.17%
5
Hangzhou Shunwang Technology
300113
-4.38%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement, Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -